Thermo Fisher rolled out the Orbitrap Astral Zoom mass spectrometer to boost throughput and sensitivity for proteomics and metabolomics studies, aiming to scale multiomics in clinical and translational research. Thermo claims the new instrument raises scan rates and pre‑accumulation to expand protein coverage and sample throughput versus prior models. Product executives and technical leads explain the hardware and software upgrades enable deeper, faster quantitative proteomics—measuring thousands of proteins per sample at higher throughput—which could accelerate biomarker discovery and large‑cohort studies. The instrument targets labs moving proteomics from niche research into population‑scale clinical investigations.